Cannabis use, cognition and brain structure in first-episode psychosis

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 209-215

  Cunha, Paulo Jannuzzi ^a   Rosa, Pedro Gomes P ^a   Ayres, Adriana de Mello ^a   Duran, Fábio L S ^a   Santos, Luciana C ^a   Scazufca, Marcia ^a   Menezes, Paulo R ^a   dos Santos, Bernardo ^a   Murray, Robin M ^b   Crippa, José Alexandre S ^a   Busatto, Geraldo F ^a   Schaufelberger, Maristela S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; Cognition; First episode psychosis (FEP); Magnetic resonance imaging; Schizophrenia; Substance use

Indexed keywords

CANNABIS;

ADULT; ARTICLE; ATTENTION DISTURBANCE; BRAIN; COGNITION; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; WECHSLER MEMORY SCALE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAZIL; CATCHMENT AREA (HEALTH); COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84878975299     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.009     Document Type: Article

References (49)

1. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) 2000, APA, Washington, DC.
2. Ayres A.M., Busatto G.F., Menezes P.R., Schaufelberger M.S., Coutinho L., Murray R.M., et al. Cognitive deficits in first-episode psychosis: a population-based study in São Paulo, Brazil. Schizophr. Res. 2007, 90:338-343.
3. Ayres A.M., Scazufca M., Menezes P.R., Nakano E.Y., Regina A.C., Schaufelberger M.S., et al. Cognitive functioning in subjects with recent-onset psychosis from a low-middle-income environment: multiple-domain deficits and longitudinal evaluation. Psychiatry Res. 2010, 179:157-164.
4. Bangalore S.S., Prasad K.M., Montrose D.M., Goradia D.D., Diwadkar V.A., Keshavan M.S. Cannabis use and brain structural alterations in first episode schizophrenia-a region of interest, voxel based morphometric study. Schizophr. Res. 2008, 99:1-6.
5. Bebbington P.E., Nayani T. The Psychosis Screening Questionnaire. Int. J. Methods Psychiatr. Res. 1995, 5:11-19.
6. Block R.I., O'Leary D.S., Ehrhardt J.C., Augustinack J.C., Ghoneim M.M., Arndt S., et al. Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000, 11:491-496.
7. Bolla K.I., Brown K., Eldreth D., Tate K., Cadet J.L. Dose-related neurocognitive effects of marijuana use. Neurology 2002, 59:1337-1343.
8. Braga R.J., Burdick K.E., Derosse P., Malhotra A.K. Cognitive and clinical outcomes associated with Cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012, 200:242-245.
9. Cahn W., Hulshoff Pol H.E., Caspers E., van Haren N.E., Schnack H.G., Kahn R.S. Cannabis and brain morphology in recent-onset schizophrenia. Schizophr. Res. 2004, 67:305-307.
10. Cousijn J., Wiers R.W., Ridderinkhof K.R., van den Brink W., Veltman D.J., Goudriaan A.E. Grey matter alterations associated with Cannabis use: results of a VBM study in heavy Cannabis users and healthy controls. NeuroImage 2012, 59:3845-3851.
11. Cunha P.J., Nicastri S., de Andrade A.G., Bolla K.I. The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: abstract reasoning, motor programming, and cognitive flexibility. Addict. Behav. 2010, 35:875-881.
12. De Hert M., Wampers M., Jendricko T., Franic T., Vidovic D., De Vriendt N., et al. Effects of Cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophr. Res. 2011, 126:270-276.
13. Fontes M.A., Bolla K.I., Cunha P.J., Almeida P.P., Jungerman F., Laranjeira R.R., et al. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic Cannabis users. J. Clin. Exp. Neuropsychol. 2011, 33:523-531.
14. Fontes M.A., Bolla K.I., Cunha P.J., Almeida P.P., Jungerman F., Laranjeira R.R., et al. Cannabis use before age 15 and subsequent executive functioning. Br. J. Psychiatry 2011, 198:442-447.
15. Hester R., Nestor L., Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic Cannabis users. Neuropsychopharmacology 2009, 34:2450-2458.
16. Jager G., Van Hell H.H., De Win M.M., Kahn R.S., Van Den Brink W., Van Ree J.M., et al. Effects of frequent Cannabis use on hippocampal activity during an associative memory task. Eur. Neuropsychopharmacol. 2007, 17:289-297.
17. Job D.E., Whalley H.C., McConnell S., Glabus M., Johnstone E.C., Lawrie S.M. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. NeuroImage 2002, 17:880-889.
18. Joyal C.C., Hallé P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr. Res. 2003, 63:297-299.
19. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
20. Koskinen J., Löhönen J., Koponen H., Isohanni M., Miettunen J. Rate of Cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36:1115-1130.
21. Lagerberg T.V., Sundet K., Aminoff S.R., Berg A.O., Ringen P.A., Andreassen, et al. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur. Arch. Psychiatry. Clin. Neurosci. 2011, 261:397-405.
22. Lezak M.D., Howieson D.B., Loring D.W. Neuropsychological Assessment 2004, Oxford University Press, New York, NY. 4th edition.
23. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yücel M. Structural MRI findings in long-term Cannabis users: what do we know?. Subst. Use Misuse 2010, 45:1787-1808.
24. Malchow B., Hasan A., Fusar-Poli P., Schmitt A., Falkai P., Wobrock T. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur. Arch. Psychiatry Clin. Neurosci. 2012, (epub ahead of print 21 August 2012). 10.1007/s00406-012-0346-3.
25. Martín-Santos R., Fagundo A.B., Crippa J.A., Atakan Z., Bhattacharyya S., Allen P., et al. Neuroimaging in Cannabis use: a systematic review of the literature. Psychol. Med. 2010, 40:383-398.
26. Matochik J.A., Eldreth D.A., Cadet J.L., Bolla K.I. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 2005, 77:23-30.
27. Menezes P.R., Scazufca M., Busatto G., Coutinho L.M., McGuire P.K., Murray R.M. Incidence of first-contact psychosis in São Paulo, Brazil. Br. J. Psychiatry 2007, 191:s102-s106.
28. Minatogawa-Chang T.M., Schaufelberger M.S., Ayres A.M., Duran F.L., Gutt E.K., Murray R.M., et al. Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis. Schizophr. Res. 2009, 113:200-209.
29. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
30. Murray R.M., Morrison P.D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 2007, 8:885-895.
31. Périco C.A.M., Duran F.L., Zanetti M.V., Santos L.C., Murray R.M., Scazufca M., et al. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects. Bipolar Disord. 2011, 13:28-40.
32. Rais M., van Haren N.E., Cahn W., Schnack H.G., Lepage C., Collins L., et al. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur. Neuropsychopharmacol. 2010, 20:855-865.
33. Rapp C., Bugra H., Riecher-Rössler A., Borgwardt S. Effects of Cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post-mortem studies. Curr. Pharm. Des. 2012, 18:5070-5080.
34. Rodríguez-Sánchez J.M., Ayesa-Arriola R., Mata I., Moreno-Calle T., Perez-Iglesias R., González-Blanch C., et al. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr. Res. 2010, 124:142-151.
35. Rosa P.G., Schaufelberger M.S., Uchida R.R., Duran F.L., Lappin J.M., Menezes P.R., et al. Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: a population-based morphometric MRI study. World J. Biol. Psychiatry 2010, 11:873-887.
36. Schaufelberger M.S., Duran F.L., Lappin J.M., Scazufca M., Amaro E., Leite C.C., et al. Grey matter abnormalities in Brazilians with first-episode psychosis. Br. J. Psychiatry 2007, 51:117-122.
37. Schaufelberger M.S., Lappin J.M., Duran F.L., Rosa P.G., Uchida R.R., Santos L.C., et al. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol. Med. 2011, 41:1677-1689.
38. Schnell T., Kleiman A., Gouzoulis-Mayfrank E., Daumann J., Becker B. Increased gray matter density in patients with schizophrenia and Cannabis use: a voxel-based morphometric study using DARTEL. Schizophr. Res. 2012, 138:183-187.
39. Solowij N., Jones K.A., Rozman M.E., Davis S.M., Ciarrochi J., Heaven P.C., et al. Reflection impulsivity in adolescent Cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology (Berl.) 2012, 219:575-586.
40. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale and description. Arch. Gen. Psychiatry 1992, 49:624-629.
41. Szeszko P.R., Robinson D.G., Sevy S., Kumra S., Rupp C.I., Betensky J.D., et al. Anterior cingulate grey-matter deficits and Cannabis use in first-episode schizophrenia. Br. J. Psychiatry 2007, 190:230-236.
42. Trzesniak C., Schaufelberger M.S., Duran F.L., Santos L.C., Rosa P.G., McGuire P.K., et al. Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study. Psychol. Med. 2012, 42:2523-2534.
43. Tzilos G.K., Cintron C.B., Wood J.B., Simpson N.S., Young A.D., Pope H.G., et al. Lack of hippocampal volume change in long-term heavy Cannabis users. Am. J. Addict. 2005, 14:64-72.
44. UNODC, United Nations Office on Drugs and Crime World Drug Report 2011 [online] 2011, UNODC, New York, NY, (http://www.unodc.org).
45. Wechsler D. Wechsler Memory Scale, 3rd edition (WMS-III) 1997, The Psychological Corporation Harcourt Brace, San Antonio, TX.
46. White J., Batty G.D. Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British cohort study. J. Epidemiol. Community Health 2012, 66:767-774.
47. Wobrock T., Sittinger H., Behrendt B., D'Amelio R., Falkai P. Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259:28-36.
48. Yücel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C., et al. Regional brain abnormalities associated with long-term heavy Cannabis use. Arch. Gen. Psychiatry 2008, 65:694-701.
49. Yücel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., et al. The impact of Cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr. Bull. 2012, 38:316-330.